Evaluating outcomes of endovascular abdominal aortic aneurysm repair
Official title: JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Run by Endologix · NCT05064540 · Data updated 2026-11-12
This study is testing two different devices for repairing abdominal aortic aneurysms to see which one works better for patients over time.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 450 (estimated) |
| Sponsor | Endologix Industry-sponsored |
| Locations | 29 sites (Huntsville, Alabama and 28 other locations) |
| Status | Recruiting |
| Started | September 20, 2021 |
| Main results expected | March 2032 |
| Study ends | March 2032 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT05064540 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 21 and older with unruptured infrarenal abdominal aortic aneurysms who are eligible for endovascular repair.
✕Probably not a fit
Patients currently participating in another trial or those with known allergies to device components may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, randomized, multi-center study aims to assess the outcomes of contemporary endovascular abdominal aortic aneurysm (EVAR) devices in a real-world population. Patients will be randomly assigned to two different device cohorts and their outcomes will be compared across primary endpoints. Follow-up evaluations will occur at discharge, and at 1, 6, 12 months, and annually for up to 5 years to monitor long-term results.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options and outcomes for patients with abdominal aortic aneurysms.
How similar studies have gone: Other studies have shown success with similar randomized approaches in evaluating EVAR outcomes, indicating a promising avenue for this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult age 21 and older * Subjects with minimum of 2 year life expectancy * Subjects have signed the informed consent document * Subjects with unruptured infrarenal AAA who are assessed by the Investigator to be eligible for endovascular Abdominal Aortic Aneurysm Repair with the trial devices. * Patient must be able and willing to comply with all required follow-up exams. Exclusion Criteria: * Currently participating in another trial where the primary endpoint has not been reached yet. * Known allergy to any of the device components * Pregnant (females of childbearing potential only) * Known connective tissue disorders * Known active infection * Subjects with pre-existing EVAR, i.e., in need of repair/intervention of a previously failed EVAR. * Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations.
Where it's running
-
University of Arizona
Tucson, Arizona, United States Recruiting -
Washington Regional Medical Center
Fayetteville, Arkansas, United States Recruiting -
Central Arkansas Veterans Healthcare System
Little Rock, Arkansas, United States Recruiting -
The Regents of the University of California, San Diego
La Jolla, California, United States Recruiting -
Veterans Affairs San Diego Healthcare System
San Diego, California, United States Recruiting -
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States Recruiting
Show 23 more locations
-
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States Recruiting -
Radiology and Imaging Specialists
Lakeland, Florida, United States Recruiting -
Baptist Hospital of Miami, Miami Cardiac and Vascular Institute
Miami, Florida, United States Recruiting -
University of Louisville
Louisville, Kentucky, United States Recruiting -
Tufts Medical Center
Boston, Massachusetts, United States Recruiting -
University of Missouri
Columbia, Missouri, United States Recruiting -
Newark Beth Israel Medical Center
Newark, New Jersey, United States Recruiting -
Icahn School of Medicine at Mount Sinai
New York, New York, United States Recruiting -
Feinstein Institutes for Medical Research (Staten Island University Hospital/Northwell Health)
Staten Island, New York, United States Recruiting -
The Cleveland Clinical Foundation
Cleveland, Ohio, United States Recruiting -
Oregon Health Sciences University
Portland, Oregon, United States Recruiting -
U.S. Department of Veterans Affairs, VA Portland Health Care System
Portland, Oregon, United States Recruiting -
Lehigh Valley Health Network
Allentown, Pennsylvania, United States Recruiting -
University of Pennsylvania
Philadelphia, Pennsylvania, United States Recruiting -
Allegheny Health Network
Pittsburgh, Pennsylvania, United States Recruiting -
Wellmont Cardiology Services
Kingsport, Tennessee, United States Recruiting -
The University of Texas Medical Branch at Galveston
Galveston, Texas, United States Recruiting -
Houston Methodist Research Institute
Houston, Texas, United States Recruiting -
Sentara Hospitals
Norfolk, Virginia, United States Recruiting -
Huntsville Hospital
Huntsville, Alabama, United States Active not recruiting -
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States Active not recruiting -
Henry Ford Hospital
Detroit, Michigan, United States Withdrawn -
The Ohio State University
Columbus, Ohio, United States Withdrawn
Study contacts
- Principal investigator: Sean Lyden, MD — The Cleveland Clinic
- Study coordinator: Noel DeSisto
- Email: ndesisto@endologix.com
- Phone: 864-270-8524
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heli-FX EndoAnchor system in abdominal aortic aneurysm patients in China
This study tests whether the Heli-FX EndoAnchor device can safely and effectively help seal and fix AAA patients at high risk of endoleaks or migration after repair.
-
TUVA BX and iCover stent grafts used in BEVAR for complex aortic aneurysms
This study looks at whether the TUVA BX and iCover stent grafts used during BEVAR procedures are safe and perform well in real-world patients with complex abdominal or thoracoabdominal aneurysms.
-
Retreatment with the Nectero EAST System for abdominal aortic aneurysm
This will try retreatment with the Nectero EAST System to repair infrarenal abdominal aortic aneurysms in adults who previously received the device under the initial protocol.
-
Abdominal CT offered alongside lung screening for people who have smoked
We will test whether mentioning a possible extra abdominal CT in the lung screening invitation changes whether people aged 55–70 who have ever smoked attend their lung screening appointment.
-
Observational registry for patients treated with GORE® endovascular devices for abdominal aortic aneurysms
This study is tracking patients who have been treated with GORE® devices for abdominal aortic aneurysms to see how they do over the next 10 years.
-
Ankura II AAA Endovascular Graft System for Abdominal Aortic Aneurysm
This trial tests whether the Ankura II stent grafts can safely and effectively treat infrarenal abdominal aortic aneurysms in adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.